ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy …,

With 13 clinical trials across multiple tumor types at Phase I to III and with the combined talent in research, clinical development and manufacturing, the …, With 13 clinical trials across multiple tumor types at Phase I to III and with the combined talent in research, clinical development and manufacturing, the …, Read More

Scroll to Top